130 related articles for article (PubMed ID: 16989688)
1. Use of an inclusive-partnership strategy in urban areas of Orissa, India, to increase compliance in a mass drug administration for the control of lymphatic filariasis.
Babu BV; Behera DK; Kerketta AS; Mishra S; Rath K; Swain BK; Mishra S; Kar SK
Ann Trop Med Parasitol; 2006 Oct; 100(7):621-30. PubMed ID: 16989688
[TBL] [Abstract][Full Text] [Related]
2. A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage.
Ramaiah KD; Vijay Kumar KN; Hosein E; Krishnamoorthy P; Augustin DJ; Snehalatha KS; Nanda B; Das PK
Ann Trop Med Parasitol; 2006 Jun; 100(4):345-61. PubMed ID: 16762115
[TBL] [Abstract][Full Text] [Related]
3. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
Babu BV; Kar SK
Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
[TBL] [Abstract][Full Text] [Related]
4. Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.
Babu BV; Satyanarayana K
Trop Doct; 2003 Apr; 33(2):79-82. PubMed ID: 12680538
[TBL] [Abstract][Full Text] [Related]
5. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S
J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209
[TBL] [Abstract][Full Text] [Related]
6. Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka.
Gunawardena GS; Ismail MM; Bradley MH; Karunaweera ND
Ann Trop Med Parasitol; 2007 Jun; 101(4):335-41. PubMed ID: 17524248
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India.
Ramaiah KD; Vijay Kumar KN; Chandrakala AV; Augustin DJ; Appavoo NC; Das PK
Trop Med Int Health; 2001 Dec; 6(12):1062-9. PubMed ID: 11737843
[TBL] [Abstract][Full Text] [Related]
8. Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance.
Babu BV; Mishra S
Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1207-13. PubMed ID: 18632125
[TBL] [Abstract][Full Text] [Related]
9. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
Ranganath BG
J Vector Borne Dis; 2010 Mar; 47(1):61-4. PubMed ID: 20231778
[No Abstract] [Full Text] [Related]
10. Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.
Roy RN; Sarkar AP; Misra R; Chakroborty A; Mondal TK; Bag K
J Health Popul Nutr; 2013 Jun; 31(2):171-7. PubMed ID: 23930334
[TBL] [Abstract][Full Text] [Related]
11. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.
Lahariya C; Mishra A
J Vector Borne Dis; 2008 Dec; 45(4):313-20. PubMed ID: 19248659
[TBL] [Abstract][Full Text] [Related]
12. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
Babu BV; Rath K; Kerketta AS; Swain BK; Mishra S; Kar SK
Trans R Soc Trop Med Hyg; 2006 May; 100(5):464-9. PubMed ID: 16288792
[TBL] [Abstract][Full Text] [Related]
13. Knowledge and perceptions about lymphatic filariasis: a study during the programme to eliminate lymphatic filariasis in an urban community of Orissa, India.
Rath K; Nath N; Shaloumy M; Swain BK; Suchismita M; Babu BV
Trop Biomed; 2006 Dec; 23(2):156-62. PubMed ID: 17322817
[TBL] [Abstract][Full Text] [Related]
14. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.
Khan AM
Indian J Med Res; 2018 Jan; 147(1):7-10. PubMed ID: 29749354
[No Abstract] [Full Text] [Related]
16. A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects.
Ramaiah KD; Das PK; Appavoo NC; Ramu K; Augustin DJ; Kumar KN; Chandrakala AV
Trop Med Int Health; 2000 Dec; 5(12):842-7. PubMed ID: 11169272
[TBL] [Abstract][Full Text] [Related]
17. Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India.
Bashar A; Nandekar SV; Shrivastava P; Singh RN; Srikrishnan P
J Vector Borne Dis; 2023; 60(3):307-316. PubMed ID: 37843242
[TBL] [Abstract][Full Text] [Related]
18. A study on coverage, compliance and awareness about mass drug administration for elimination of lymphatic filariasis in a district of West Bengal, India.
Karmakar PR; Mitra K; Chatterjee A; Jana PK; Bhattacharya S; Lahiri SK
J Vector Borne Dis; 2011 Jun; 48(2):101-4. PubMed ID: 21715733
[No Abstract] [Full Text] [Related]
19. A study to compare the effect of adding 12 days DEC regimen to 6 years annual mass drug administration to eliminate microfilaraemia infection in the community in rural Kanpur, Uttar Pradesh, India.
Kumar A; Sachan P; Bajpei A; Singh T
J Commun Dis; 2013; 45(1-2):33-40. PubMed ID: 25141552
[TBL] [Abstract][Full Text] [Related]
20. Towards elimination of lymphatic filariasis in India.
Das PK; Ramaiah KD; Augustin DJ; Kumar A
Trends Parasitol; 2001 Oct; 17(10):457-60. PubMed ID: 11587940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
